Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

NYMXF

NYMOX PHARMACEUTICAL CORP

CIK 0001018735 · OTC

OTCHealth CareIn Vitro & In Vivo Diagnostic Substances
$0.12
↑ 0.00 (0.00%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Overall read: BullishOverall score · based on 2/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Technicals; Excluded: Ownership, Options (no data)

Key stats

Market Cap
$11.34M
P/E Ratio
-2.53
EPS
-0.05
Dividend Yield
Not covered
52W Position
53%
Beta
-1.17

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
-1.67
P/S
Not covered
EV/Revenue
Not covered
ROE
66.3%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 53%
$0.03$0.20

Latest Financials

2024-12-31 FY
Revenue
–
Net Income
-$4.49M
Total Assets
$654.00K
Free Cash Flow
-$2.60M

Recent news